{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:21:17Z","timestamp":1787844077335,"version":"build-2784847793"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims:<\/jats:title>\n                    <jats:p>Lymphatic filariasis (LF), a tropical illness caused by mosquito-borne parasites, is a serious public health concern in endemic areas such as Jharkhand, India. The illness continues despite efforts by the World Health Organization and the Mass Drug Administration (MDA). This study aims to investigates the clinical and demographic profiles of patients with LF and assesses coverage of MDA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This cross-sectional study included 100 patients with LF who presented to the General Surgery Outpatient Department. Interviews, clinical exams, and semi-structured questionnaires were used to obtain information about sociodemographic profile, clinical symptoms and MDA coverage. Descriptive statistics and Chi-square tests were used to find the association between clinical profile, drug consumption, and sociodemographic profiles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The study revealed that participants were mostly middle-aged, married (55%), from low-income families (86%), and had varied degrees of hydrocele and lymphedema, with nearly 70% experiencing scrotal enlargement. Furthermore, 44% of patients reported insufficient MDA coverage. There were significant connections found between the size of the hydrocele (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01) and actual drug consumption (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01) with socioeconomic status.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The study highlights important clinical, sociodemographic patterns, and reveal MDA coverage gaps among patients with LF. There is a need of targeted education and enhanced treatment access to improve MDA effectiveness and achieving LF eradication by 2030.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_2056_24","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T06:00:21Z","timestamp":1752904821000},"page":"2902-2907","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Clinical profile and Mass Drug Administration coverage in patients with lymphatic filariasis: A descriptive study"],"prefix":"10.4103","volume":"14","author":[{"given":"Sumit","family":"Pareek","sequence":"first","affiliation":[{"name":"MBBS Students, All India Institute of Medical Sciences, Deoghar, Jharkhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishit","family":"Ranjan","sequence":"additional","affiliation":[{"name":"Department of General Surgery, All India Institute of Medical Sciences, Deoghar, Jharkhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipin","family":"Patidar","sequence":"additional","affiliation":[{"name":"College of Nursing, All India Institute of Medical Sciences, Deoghar, Jharkhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv Kumar","family":"Mudgal","sequence":"additional","affiliation":[{"name":"College of Nursing, All India Institute of Medical Sciences, Deoghar, Jharkhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratima","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Microbiology, All India Institute of Medical Sciences, Deoghar, Jharkhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"issue":"(5 Suppl)","key":"R6-20250804","first-page":"29","article-title":"Introduction of triple-drug therapy for accelerating lymphatic filariasis elimination in India: Lessons learned","volume":"106","author":"Tripathi","year":"2022","journal-title":"Am J Trop Med Hyg"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1365-3156.2000.00515.x","article-title":"Development of rapid assessment procedures for the delimitation of lymphatic filariasis-endemic areas","volume":"5","author":"Srividya","year":"2000","journal-title":"Trop Med Int Health"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/lrb.2020.0014","article-title":"Disease burden estimation of Lymphatic Filariasis in an endemic area","volume":"20","author":"Nagavarapu","year":"2022","journal-title":"Lymphat Res Biol"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4103\/jfmpc.jfmpc_491_20","article-title":"Lifestyle behavior of budding health care professionals: A cross-sectional descriptive study","volume":"9","author":"Sharma","year":"2020","journal-title":"J Family Med Prim Care"},{"key":"R11-20250804","first-page":"24","article-title":"Surgical management of morbidity due to lymphatic filariasis: The usefulness of a standardized international clinical classification of hydroceles","volume":"29","author":"Capuano","year":"2012","journal-title":"Trop Biomed"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"e0011457","DOI":"10.1371\/journal.pntd.0011457","article-title":"Socio-economic and environmental factors associated with high lymphatic filariasis morbidity prevalence distribution in Bangladesh","volume":"17","author":"Williams","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"e33779","DOI":"10.1371\/journal.pone.0033779","article-title":"A cohort study of lymphatic filariasis on socio-economic conditions in Andhra Pradesh, India","volume":"7","author":"Upadhyayula","year":"2012","journal-title":"PLoS One"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/lrb.2019.0014","article-title":"Lymphedema Impact and Prevalence International Study: The Canadian data","volume":"17","author":"Keast","year":"2019","journal-title":"Lymphat Res Biol"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/qjmed\/hcg126","article-title":"Lymphoedema: An underestimated health problem","volume":"96","author":"Moffatt","year":"2003","journal-title":"QJM"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3389\/fpubh.2020.00231","article-title":"Socioeconomic status and access to healthcare: Interrelated drivers for healthy aging","volume":"8","author":"McMaughan","year":"2020","journal-title":"Front Public Health"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/jfmpc.jfmpc_1149_22","article-title":"Coverage of mass drug administration (MDA) and operational issues in elimination of lymphatic filariasis in selected districts of Jharkhand, India","volume":"12","author":"Kumar","year":"2023","journal-title":"J Family Med Prim Care"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"12971","DOI":"10.3390\/ijerph191912971","article-title":"Factors associated with the acceptability of mass drug administration for filariasis: A systematic review","volume":"19","author":"Abdul Halim","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1177\/00494755221098532","article-title":"Mass drug administration for lymphatic filariasis elimination amidst COVID-19 pandemic in Odisha, India: A step towards achieving SDG-3","volume":"52","author":"Sinha","year":"2022","journal-title":"Trop Doct"},{"key":"R21-20250804","first-page":"511","article-title":"Vitamin D: A cheap yet effective bullet against coronavirus disease-19 \u2013Are we convinced yet?","volume":"10","author":"Sharma","year":"2020","journal-title":"Natl J Physiol Pharm Pharmacol"},{"key":"R22-20250804","first-page":"9","article-title":"Trend of MDA coverage and compliance in the four endemic districts of Jharkhand: A secondary data analysis","volume":"5","author":"Haider","year":"2014","journal-title":"Healthline"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"1297954","DOI":"10.3389\/fphar.2024.1297954","article-title":"Factors influencing implementation of mass drug administration for lymphatic filariasis elimination: A mixed-method study in Odisha, India","volume":"15","author":"Ratna","year":"2024","journal-title":"Front Pharmacol"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"287","DOI":"10.47203\/IJCH.2018.v30i03.017","article-title":"Mass drug administration (MDA) for elimination of lymphatic filariasis: Experiences from Nayagarh district of Odisha, India","volume":"30","author":"Bhatia","year":"2018","journal-title":"Indian J Community Health"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.cegh.2020.05.018","article-title":"Self-medication practices with antibiotics among nursing students: A cross-sectional descriptive survey at tertiary care teaching hospital in Uttarakhand","volume":"8","author":"Sharma","year":"2020","journal-title":"Clin Epidemiol Glob Health"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2229-5070.105175","article-title":"Factors determining noncompliance to mass drug administration for lymphatic filariasis elimination","volume":"2","author":"Nujum","year":"2012","journal-title":"Trop Parasitol"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_2056_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:04:44Z","timestamp":1787843084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_2056_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_2056_24","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"2024-12-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}